Trials / Unknown
UnknownNCT03596060
Regional vs General Anesthesia in Patients With Hip Fracture Under Treatment With Clopidogrel
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Larissa University Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study compares general to regional anesthesia concerning morbidity and mortality in patients older than or equal to 65 years old who receive clopidogrel and are to be submitted in hip fracture surgery. Half of participants will receive general anesthesia the first 48 hours and the other half will receive regional anesthesia after 5 days of the discontinuation of clopidogrel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fentanyl | Fentanyl will be used for introduction in both regional and general anesthesia. It will also be used for general anesthesia maintenance. |
| DRUG | Propofol | Propofol will be used for introduction in general anesthesia. |
| DRUG | Rocuronium | Rocuronium will be used for introduction in general anesthesia. |
| DRUG | Chirochaine | Chirochaine 0.5% will be used in regional anesthesia. |
| DRUG | Morphine | Morphine will be administered bolus iv in General anesthesia group postoperatively before patients leave OR. |
Timeline
- Start date
- 2017-10-20
- Primary completion
- 2022-05-01
- Completion
- 2022-10-01
- First posted
- 2018-07-23
- Last updated
- 2021-09-28
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT03596060. Inclusion in this directory is not an endorsement.